COVID-19-Associated Rhino-orbital mucormycosis: Presentation and outcome.
Saudi J Ophthalmol
; 37(1): 72-75, 2023.
Article
in English
| MEDLINE | ID: covidwho-2279352
ABSTRACT
We are reporting four accounts of rhino-orbital mucormycosis in patients during and after recovery from SARS-CoV-2 infection. The patients were diagnosed and treated for COVID-19 according to the current treatment protocols, following which they presented with sudden proptosis, ophthalmoplegia, and conjunctival injection, confirmed by magnetic resonance imaging and histopathological examination. The patients were treated with intravenous liposomal amphotericin B, and the outcome was observed. Early diagnosis and prompt intervention can substantially reduce the morbidity and mortality rates in these patients.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Type of study:
Case report
/
Prognostic study
Language:
English
Journal:
Saudi J Ophthalmol
Year:
2023
Document Type:
Article
Affiliation country:
Sjopt.sjopt_154_21
Similar
MEDLINE
...
LILACS
LIS